BioNexus Gene Lab Corp amends CEO/acting CFO compensation: base salary $35k/month effective July 1, 2024, plus back pay

BioNexus Gene Lab Corp

Base salary for CEO/acting CFO Su-Leng Tan Lee set at $35,000 per month effective July 1, 2024.
Company will recognize back pay at this rate from when Tan Lee began serving as CEO and CFO.
Inducement Award Entitlement to be finalized by Compensation Committee in Q3 2024.
Amendment approved by Compensation Committee on June 30, 2024.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.